People are suing Novo Nordisk and Eli Lilly and Company due to legal issues surrounding their GLP-1 receptor agonist drugs, with plaintiffs bringing forth substantially similar allegations against both drug manufacturers. These lawsuits claim that the companies failed to adequately warn consumers about the potentially severe side effects and health complications associated with their drugs.